Under the slogan of our partnership with physicians and pharmacists “Partners in Health” , Ibn Alhaytham pharmaceutical industries sponsored a study about type II diabetic patients using Sitacretin Plus product ( Sitagliptin + Metformin ) last Ramadan during the year of 2012 in cooperation with Dr. Yaman Alsaied.

Ibn Alhaytham pharmaceutical industries recently launched a new drug called Energetic which is full of vitamins and minerals. It is distinguished from other drugs because it has been strengthened by co-enzyme (Q10).

Under the slogan of Ibn Al haytham Pharmaceutical Industries (Partners in Health), the company promotes partnership with doctors in the field of Health & patients public interest in addition to Health awareness (enlightenment). For the purpose of society service and the enhancement of scientific research in Syria, Ibn Al Haytham Pharmaceutical Industries is working on an observational study for patients with type 2 diabetes in Syria through a survey on Sitacretin Plus product which is consisted of (Sitagliptin + Metformin).

Ibn Alhaytham pharmaceutical industries recently launched a new drug called Glucosamine Gold which contains the essential materials for joints reparation and preventing joints degeneration. Those materials are (Glucosamine, Chondroitin and MSM) in addition to wild roses abstracts and ginger roots that have an anti- inflammatory and pain reliever properties with important vitamins and minerals for joints safety.

One of the most important essential pillars adopted by the national companies of pharmaceutical industry is coping with the development in pharmaceutical and medical fields, particularly in chronic diseases field like (Hypertension, Diabetes Mellitus and chronic arthritis).

Yesterday evening was the opening of a conference doctor’s room in the fifth floor of new hospital, Ibn – Roshid after the completion of maintenance engineering and the supplement of the necessary equipments like computers, projectors , sound equipment , seats and meeting tables , to become fully ready for medical lectures and daily doctors' meetings.

Ibn Al–Haytham Pharma sponsored a graduation ceremony for the sixth students group of Pharmacy university for the year 2009 – 2010 in the grandstand at the Faculty of Arts , Al–Baath University in Homs.

In the recent period, the interest of Syrian pharmaceutical companies has been increased toward creating private symposiums or conferences to support knowledge exchange among physicians.

Obesity is considered as a dangerous factor of many diseases like diabetes Mellitus, hypertension, blood fat disorders and cardiac diseases.

Ibn-Alhaytham pharma held its second cardiology conference in the period between 13 – 16 May 2010 at Grand Rotana Resort, Sharm Alshaikh, Egypt.